Article
Genomic analyses of high-grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities.
Molecular oncology - 1 Dec 2021
Mahdi Haider, Joehlin-Price Amy, Elishaev Esther, Dowlati Afshin, Abbas Ata
Abstract excerpt
High-grade neuroendocrine carcinoma of gynecologic origin (NEC-GYN) is a highly aggressive cancer that often affects young women. The clinical management of NEC-GYN is typically extrapolated from its counterpart, small cell carcinoma of the lung (SCLC), but, unfortunately, available therapies have limited benefit. In our NEC-GYN cohort, median progression-free survival (PFS) and overall survival (OS) were 1 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
